Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration

Claudia Traidl-Hoffmann; Jamie Afghani; Cezmi Akdis; Mubecel Akdis; Handan Aydin; Katja Barenfaller; Heidrun Behrendt; Thomas Bieber; Paul Bigliardi; Mei Bigliardi-Qi; Charlotte Menne Bonefeld; Stefanie Bosch; Marie Charlotte Bruggen; Sebastian Diemert; Hans-Werner Duchna; Martina Fahndrich; Danielle Fehr; Marc Fellmann; Remo Frei; Lena H. Garvey; Raschid Gharbo; Mehmet Goekkaya; Karin Grando; Carole Guillet; Erman Guler; Jan Gutermuth; Nadine Herrmann; Dirk Jan Hijnen; Claudia Huelpuesch; Alan D. Irvine; Erika Jensen-Jarolim; Heidi H. Kong; Hillel Koren; Claudia C. V. Lang; Roger Lauener; Laura Maintz; Pierre-Yves Mantel; Emanuel Maverakis; Matthias Mohrenschlager; Svenja Mueller; Kari Nadeau; Avidan U. Neumann; Liam O'Mahony; Fahafahantsoa Rapelanoro Rabenja; Harald Renz; Claudio Rhyner; Ernst Rietschel; Johannes Ring; Caroline Roduit; Mari Sasaki; Mirjam Schenk; Jens Schroeder; Dagmar Simon; Hans-Uwe Simon; Milena Sokolowska; Sonja Staender; Martin Steinhoff; Doris Straub Piccirillo; Alain Taieb; Roberto Takaoka; Martin Tapparo; Henrique Teixeira; Jacob Pontoppidan Thyssen; Stephan Traidl; Miriam Uhlmann; Willem van de Veen; Marianne van Hage; Christian Virchow; Andreas Wollenberg; Mitamura Yasutaka; Alexander Zink; Peter Schmid-Grendelmeier

doi:10.1111/all.16247

Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration

Claudia Traidl-Hoffmann^*, Jamie Afghani, Cezmi Akdis, Mubecel Akdis, Handan Aydin, Katja Barenfaller, Heidrun Behrendt, Thomas Bieber, Paul Bigliardi, Mei Bigliardi-Qi, Charlotte Menne Bonefeld, Stefanie Bosch, Marie Charlotte Bruggen, Sebastian Diemert, Hans-Werner Duchna, Martina Fahndrich, Danielle Fehr, Marc Fellmann, Remo Frei, Lena H. GarveyRaschid Gharbo, Mehmet Goekkaya, Karin Grando, Carole Guillet, Erman Guler, Jan Gutermuth, Nadine Herrmann, Dirk Jan Hijnen, Claudia Huelpuesch, Alan D. Irvine, Erika Jensen-Jarolim, Heidi H. Kong, Hillel Koren, Claudia C. V. Lang, Roger Lauener, Laura Maintz, Pierre-Yves Mantel, Emanuel Maverakis, Matthias Mohrenschlager, Svenja Mueller, Kari Nadeau, Avidan U. Neumann, Liam O'Mahony, Fahafahantsoa Rapelanoro Rabenja, Harald Renz, Claudio Rhyner, Ernst Rietschel, Johannes Ring, Caroline Roduit, Mari Sasaki, Mirjam Schenk, Jens Schroeder, Dagmar Simon, Hans-Uwe Simon, Milena Sokolowska, Sonja Staender, Martin Steinhoff, Doris Straub Piccirillo, Alain Taieb, Roberto Takaoka, Martin Tapparo, Henrique Teixeira, Jacob Pontoppidan Thyssen, Stephan Traidl, Miriam Uhlmann, Willem van de Veen, Marianne van Hage, Christian Virchow, Andreas Wollenberg, Mitamura Yasutaka, Alexander Zink, Peter Schmid-Grendelmeier

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Review article › Academic › peer-review

3 Citations (Scopus)

10 Downloads (Pure)

Abstract

The 4th Davos Declaration was developed during the Global Allergy Forum in Davos which aimed to elevate the care of patients with atopic dermatitis (AD) by uniting experts and stakeholders. The forum addressed the high prevalence of AD, with a strategic focus on advancing research, treatment, and management to meet the evolving challenges in the field. This multidisciplinary forum brought together top leaders from research, clinical practice, policy, and patient advocacy to discuss the critical aspects of AD, including neuroimmunology, environmental factors, comorbidities, and breakthroughs in prevention, diagnosis, and treatment. The discussions were geared towards fostering a collaborative approach to integrate these advancements into practical, patient-centric care. The forum underlined the mounting burden of AD, attributing it to significant environmental and lifestyle changes. It acknowledged the progress in understanding AD and in developing targeted therapies but recognized a gap in translating these innovations into clinical practice. Emphasis was placed on the need for enhanced awareness, education, and stakeholder engagement to address this gap effectively and to consider environmental and lifestyle factors in a comprehensive disease management strategy. The 4th Davos Declaration marks a significant milestone in the journey to improve care for people with AD. By promoting a holistic approach that combines research, education, and clinical application, the Forum sets a roadmap for stakeholders to collaborate to improve patient outcomes in AD, reflecting a commitment to adapt and respond to the dynamic challenges of AD in a changing world.

Original language	English
Pages (from-to)	2605-2624
Number of pages	20
Journal	Allergy
Volume	79
Issue number	10
DOIs	https://doi.org/10.1111/all.16247
Publication status	E-pub ahead of print - 4 Aug 2024

Bibliographical note

Publisher Copyright:
© 2024 The Author(s). Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Access to Document

10.1111/all.16247Licence: CC BY-NC

Allergy - 2024 - Traidl‐Hoffmann - Navigating the evolving landscape of atopic dermatitis Challenges and futureFinal published version, 7.4 MBLicence: CC BY-NC

Cite this

Traidl-Hoffmann, C., Afghani, J., Akdis, C., Akdis, M., Aydin, H., Barenfaller, K., Behrendt, H., Bieber, T., Bigliardi, P., Bigliardi-Qi, M., Bonefeld, C. M., Bosch, S., Bruggen, M. C., Diemert, S., Duchna, H.-W., Fahndrich, M., Fehr, D., Fellmann, M., Frei, R., ... Schmid-Grendelmeier, P. (2024). Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration. Allergy, 79(10), 2605-2624. Advance online publication. https://doi.org/10.1111/all.16247

@article{5cb89a0beddf437595f334c59cc196f3,

title = "Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration",

abstract = "The 4th Davos Declaration was developed during the Global Allergy Forum in Davos which aimed to elevate the care of patients with atopic dermatitis (AD) by uniting experts and stakeholders. The forum addressed the high prevalence of AD, with a strategic focus on advancing research, treatment, and management to meet the evolving challenges in the field. This multidisciplinary forum brought together top leaders from research, clinical practice, policy, and patient advocacy to discuss the critical aspects of AD, including neuroimmunology, environmental factors, comorbidities, and breakthroughs in prevention, diagnosis, and treatment. The discussions were geared towards fostering a collaborative approach to integrate these advancements into practical, patient-centric care. The forum underlined the mounting burden of AD, attributing it to significant environmental and lifestyle changes. It acknowledged the progress in understanding AD and in developing targeted therapies but recognized a gap in translating these innovations into clinical practice. Emphasis was placed on the need for enhanced awareness, education, and stakeholder engagement to address this gap effectively and to consider environmental and lifestyle factors in a comprehensive disease management strategy. The 4th Davos Declaration marks a significant milestone in the journey to improve care for people with AD. By promoting a holistic approach that combines research, education, and clinical application, the Forum sets a roadmap for stakeholders to collaborate to improve patient outcomes in AD, reflecting a commitment to adapt and respond to the dynamic challenges of AD in a changing world.",

author = "Claudia Traidl-Hoffmann and Jamie Afghani and Cezmi Akdis and Mubecel Akdis and Handan Aydin and Katja Barenfaller and Heidrun Behrendt and Thomas Bieber and Paul Bigliardi and Mei Bigliardi-Qi and Bonefeld, {Charlotte Menne} and Stefanie Bosch and Bruggen, {Marie Charlotte} and Sebastian Diemert and Hans-Werner Duchna and Martina Fahndrich and Danielle Fehr and Marc Fellmann and Remo Frei and Garvey, {Lena H.} and Raschid Gharbo and Mehmet Goekkaya and Karin Grando and Carole Guillet and Erman Guler and Jan Gutermuth and Nadine Herrmann and Hijnen, {Dirk Jan} and Claudia Huelpuesch and Irvine, {Alan D.} and Erika Jensen-Jarolim and Kong, {Heidi H.} and Hillel Koren and Lang, {Claudia C. V.} and Roger Lauener and Laura Maintz and Pierre-Yves Mantel and Emanuel Maverakis and Matthias Mohrenschlager and Svenja Mueller and Kari Nadeau and Neumann, {Avidan U.} and Liam O'Mahony and Rabenja, {Fahafahantsoa Rapelanoro} and Harald Renz and Claudio Rhyner and Ernst Rietschel and Johannes Ring and Caroline Roduit and Mari Sasaki and Mirjam Schenk and Jens Schroeder and Dagmar Simon and Hans-Uwe Simon and Milena Sokolowska and Sonja Staender and Martin Steinhoff and Piccirillo, {Doris Straub} and Alain Taieb and Roberto Takaoka and Martin Tapparo and Henrique Teixeira and Thyssen, {Jacob Pontoppidan} and Stephan Traidl and Miriam Uhlmann and {van de Veen}, Willem and {van Hage}, Marianne and Christian Virchow and Andreas Wollenberg and Mitamura Yasutaka and Alexander Zink and Peter Schmid-Grendelmeier",

note = "Publisher Copyright: {\textcopyright} 2024 The Author(s). Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.",

year = "2024",

month = aug,

day = "4",

doi = "10.1111/all.16247",

language = "English",

volume = "79",

pages = "2605--2624",

journal = "Allergy",

issn = "0105-4538",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "10",

}

Traidl-Hoffmann, C, Afghani, J, Akdis, C, Akdis, M, Aydin, H, Barenfaller, K, Behrendt, H, Bieber, T, Bigliardi, P, Bigliardi-Qi, M, Bonefeld, CM, Bosch, S, Bruggen, MC, Diemert, S, Duchna, H-W, Fahndrich, M, Fehr, D, Fellmann, M, Frei, R, Garvey, LH, Gharbo, R, Goekkaya, M, Grando, K, Guillet, C, Guler, E, Gutermuth, J, Herrmann, N, Hijnen, DJ, Huelpuesch, C, Irvine, AD, Jensen-Jarolim, E, Kong, HH, Koren, H, Lang, CCV, Lauener, R, Maintz, L, Mantel, P-Y, Maverakis, E, Mohrenschlager, M, Mueller, S, Nadeau, K, Neumann, AU, O'Mahony, L, Rabenja, FR, Renz, H, Rhyner, C, Rietschel, E, Ring, J, Roduit, C, Sasaki, M, Schenk, M, Schroeder, J, Simon, D, Simon, H-U, Sokolowska, M, Staender, S, Steinhoff, M, Piccirillo, DS, Taieb, A, Takaoka, R, Tapparo, M, Teixeira, H, Thyssen, JP, Traidl, S, Uhlmann, M, van de Veen, W, van Hage, M, Virchow, C, Wollenberg, A, Yasutaka, M, Zink, A & Schmid-Grendelmeier, P 2024, 'Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration', Allergy, vol. 79, no. 10, pp. 2605-2624. https://doi.org/10.1111/all.16247

TY - JOUR

T1 - Navigating the evolving landscape of atopic dermatitis

T2 - Challenges and future opportunities: The 4th Davos declaration

AU - Traidl-Hoffmann, Claudia

AU - Afghani, Jamie

AU - Akdis, Cezmi

AU - Akdis, Mubecel

AU - Aydin, Handan

AU - Barenfaller, Katja

AU - Behrendt, Heidrun

AU - Bieber, Thomas

AU - Bigliardi, Paul

AU - Bigliardi-Qi, Mei

AU - Bonefeld, Charlotte Menne

AU - Bosch, Stefanie

AU - Bruggen, Marie Charlotte

AU - Diemert, Sebastian

AU - Duchna, Hans-Werner

AU - Fahndrich, Martina

AU - Fehr, Danielle

AU - Fellmann, Marc

AU - Frei, Remo

AU - Garvey, Lena H.

AU - Gharbo, Raschid

AU - Goekkaya, Mehmet

AU - Grando, Karin

AU - Guillet, Carole

AU - Guler, Erman

AU - Gutermuth, Jan

AU - Herrmann, Nadine

AU - Hijnen, Dirk Jan

AU - Huelpuesch, Claudia

AU - Irvine, Alan D.

AU - Jensen-Jarolim, Erika

AU - Kong, Heidi H.

AU - Koren, Hillel

AU - Lang, Claudia C. V.

AU - Lauener, Roger

AU - Maintz, Laura

AU - Mantel, Pierre-Yves

AU - Maverakis, Emanuel

AU - Mohrenschlager, Matthias

AU - Mueller, Svenja

AU - Nadeau, Kari

AU - Neumann, Avidan U.

AU - O'Mahony, Liam

AU - Rabenja, Fahafahantsoa Rapelanoro

AU - Renz, Harald

AU - Rhyner, Claudio

AU - Rietschel, Ernst

AU - Ring, Johannes

AU - Roduit, Caroline

AU - Sasaki, Mari

AU - Schenk, Mirjam

AU - Schroeder, Jens

AU - Simon, Dagmar

AU - Simon, Hans-Uwe

AU - Sokolowska, Milena

AU - Staender, Sonja

AU - Steinhoff, Martin

AU - Piccirillo, Doris Straub

AU - Taieb, Alain

AU - Takaoka, Roberto

AU - Tapparo, Martin

AU - Teixeira, Henrique

AU - Thyssen, Jacob Pontoppidan

AU - Traidl, Stephan

AU - Uhlmann, Miriam

AU - van de Veen, Willem

AU - van Hage, Marianne

AU - Virchow, Christian

AU - Wollenberg, Andreas

AU - Yasutaka, Mitamura

AU - Zink, Alexander

AU - Schmid-Grendelmeier, Peter

PY - 2024/8/4

Y1 - 2024/8/4

N2 - The 4th Davos Declaration was developed during the Global Allergy Forum in Davos which aimed to elevate the care of patients with atopic dermatitis (AD) by uniting experts and stakeholders. The forum addressed the high prevalence of AD, with a strategic focus on advancing research, treatment, and management to meet the evolving challenges in the field. This multidisciplinary forum brought together top leaders from research, clinical practice, policy, and patient advocacy to discuss the critical aspects of AD, including neuroimmunology, environmental factors, comorbidities, and breakthroughs in prevention, diagnosis, and treatment. The discussions were geared towards fostering a collaborative approach to integrate these advancements into practical, patient-centric care. The forum underlined the mounting burden of AD, attributing it to significant environmental and lifestyle changes. It acknowledged the progress in understanding AD and in developing targeted therapies but recognized a gap in translating these innovations into clinical practice. Emphasis was placed on the need for enhanced awareness, education, and stakeholder engagement to address this gap effectively and to consider environmental and lifestyle factors in a comprehensive disease management strategy. The 4th Davos Declaration marks a significant milestone in the journey to improve care for people with AD. By promoting a holistic approach that combines research, education, and clinical application, the Forum sets a roadmap for stakeholders to collaborate to improve patient outcomes in AD, reflecting a commitment to adapt and respond to the dynamic challenges of AD in a changing world.

AB - The 4th Davos Declaration was developed during the Global Allergy Forum in Davos which aimed to elevate the care of patients with atopic dermatitis (AD) by uniting experts and stakeholders. The forum addressed the high prevalence of AD, with a strategic focus on advancing research, treatment, and management to meet the evolving challenges in the field. This multidisciplinary forum brought together top leaders from research, clinical practice, policy, and patient advocacy to discuss the critical aspects of AD, including neuroimmunology, environmental factors, comorbidities, and breakthroughs in prevention, diagnosis, and treatment. The discussions were geared towards fostering a collaborative approach to integrate these advancements into practical, patient-centric care. The forum underlined the mounting burden of AD, attributing it to significant environmental and lifestyle changes. It acknowledged the progress in understanding AD and in developing targeted therapies but recognized a gap in translating these innovations into clinical practice. Emphasis was placed on the need for enhanced awareness, education, and stakeholder engagement to address this gap effectively and to consider environmental and lifestyle factors in a comprehensive disease management strategy. The 4th Davos Declaration marks a significant milestone in the journey to improve care for people with AD. By promoting a holistic approach that combines research, education, and clinical application, the Forum sets a roadmap for stakeholders to collaborate to improve patient outcomes in AD, reflecting a commitment to adapt and respond to the dynamic challenges of AD in a changing world.

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:001283211700001&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1111/all.16247

DO - 10.1111/all.16247

M3 - Review article

C2 - 39099205

SN - 0105-4538

VL - 79

SP - 2605

EP - 2624

JO - Allergy

JF - Allergy

IS - 10

ER -

Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this